Kazia Therapeutics (KZIA) Operating Expenses (2016 - 2018)

Kazia Therapeutics has reported Operating Expenses for 3 years, with the latest figure at $73.89 in Q4 2018.

• For the quarter ending Q4 2018, Operating Expenses fell 99.95% year-over-year to $73.89; the trailing twelve-month figure through Jun 2020 stood at $73.89 (down 99.95% YoY), and the FY2025 full-year result was $10.3 million, down 49.61% from the prior year.
• Operating Expenses for Q4 2018 stood at $73.89, down from $156425.5 in the prior quarter.
• The five-year high for Operating Expenses was $156425.5 in Q4 2017, with the low at $73.89 in Q4 2018.
• Historically, Operating Expenses has averaged $64628.1 across 3 years, with a median of $37384.9 in 2016.
• Annual changes were most pronounced in 2017 — Operating Expenses soared 318.42% — and 2018, when it sank 99.95%.
• Kazia Therapeutics' Operating Expenses stood at $37384.9 in 2016, then soared by 318.42% to $156425.5 in 2017, then slumped by 99.95% to $73.89 in 2018.
• The last three Operating Expenses figures came in at $73.89 (Q4 2018), $156425.5 (Q4 2017), and $37384.9 (Q4 2016), per Business Quant data.